Fine-Mapping Angiotensin-Converting Enzyme Gene: Separate QTLs Identified for Hypertension and for ACE Activity

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Chung, Chia Min ^a,b   Wang, Ruey Yun ^c   Fann, Cathy S J ^a   Chen, Jaw Wen ^d,e   Jong, Yuh Shiun ^f   Jou, Yuh Shan ^a   Yang, Hsin Chou ^g   Kang, Chih Sen ^h   Chen, Chien Chung ⁱ   Chang, Huan Cheng ⁱ   Pan, Wen Harn ^a,b  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^f TAO YUAN GENERAL HOSPITAL   (Taiwan)

^g INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

^h MIN SHENG GENERAL HOSPITAL   (Taiwan)

ⁱ LIN SHIN HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

3' UNTRANSLATED REGION; ACE GENE; ADULT; ARTICLE; ENZYME ACTIVITY; EXON; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; INTRON; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PEDIGREE; PROMOTER REGION; QUANTITATIVE TRAIT LOCUS MAPPING; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; EXONS; FEMALE; HAPLOTYPES; HUMANS; HYPERTENSION; INTRONS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PEDIGREE; PEPTIDYL-DIPEPTIDASE A; PHENOTYPE; POLYMORPHISM, GENETIC; QUANTITATIVE TRAIT LOCI; TAIWAN;

EID: 84874627047     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056119     Document Type: Article

References (33)

1. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JC, (2006) ACE polymorphisms. Circ Res 98: 1123-1133.
2. Ng DP, Placha G, Choo S, Chia KS, Warram JH, et al. (2006) A disease haplotype for advanced nephropathy in type 2 diabetes at the ACE locus. Diabetes 55: 2660-2663.
3. Danilczyk U, Penninger JM, (2006) Angiotensin-converting enzyme II in the heart and the kidney. Circ Res 98: 463-471.
4. Schurmann M, (2003) Angiotensin-converting enzyme gene polymorphisms in patients with pulmonary sarcoidosis: impact on disease severity. Am J Pharmacogenomics 3: 233-243.
5. Lehmann DJ, Cortina-Borja M, Warden DR, Smith AD, Sleegers K, et al. (2005) Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease. Am J Epidemiol 162: 305-317.
6. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, et al. (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346.
7. Zhu X, Bouzekri N, Southam L, Cooper RS, Adeyemo A, et al. (2001) Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 68: 1139-1148.
8. Pan WH, Lynn KS, Chen CH, Wu YL, Lin CY, et al. (2006) Using endophenotypes for pathway clusters to map complex disease genes. Genet Epidemiol 30: 143-154.
9. Barley J, Blackwood A, Miller M, Markandu ND, Carter ND, et al. (1996) Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens 10: 31-35.
10. O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, et al. (1998) Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 97: 1766-1772.
11. Keavney B, McKenzie CA, Connell JM, Julier C, Ratcliffe PJ, et al. (1998) Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet 7: 1745-1751.
12. Zhu X, McKenzie CA, Forrester T, Nickerson DA, Broeckel U, et al. (2000) Localization of a small genomic region associated with elevated ACE. Am J Hum Genet 67: 1144-1153.
13. McKenzie CA, Abecasis GR, Keavney B, Forrester T, Ratcliffe PJ, et al. (2001) Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE). Hum Mol Genet 10: 1077-1084.
14. Cox R, Bouzekri N, Martin S, Southam L, Hugill A, et al. (2002) Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides. Hum Mol Genet 11: 2969-2977.
15. Soubrier F, Martin S, Alonso A, Visvikis S, Tiret L, et al. (2002) High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity. Eur J Hum Genet 10: 553-561.
16. Bouzekri N, Zhu X, Jiang Y, McKenzie CA, Luke A, et al. (2004) Angiotensin I-converting enzyme polymorphisms, ACE level and blood pressure among Nigerians, Jamaicans and African-Americans. Eur J Hum Genet 12: 460-468.
17. Wang RY, Chung CM, Fann CS, Yang HC, Chen JW, et al. (2008) Genome-wide scan for quantitative ACE activity in Taiwan young-onset hypertension study. Hum Hered 65: 85-90.
18. Castiglione CM, Deinard AS, Speed WC, Sirugo G, Rosenbaum HC, et al. (1995) Evolution of haplotypes at the DRD2 locus. Am J Hum Genet 57: 1445-1456.
19. Kasahara Y, Ashihara Y, (1981) Colorimetry of angiotensin-I converting enzyme activity in serum. Clin Chem 27: 1922-1925.
20. Chung CM, Wang RY, Chen JW, Fann CS, Leu HB, et al. (2010) A genome-wide association study identifies new loci for ACE activity: potential implications for response to ACE inhibitor. Pharmacogenomics J 10: 537-544.
21. Pan WH, Fann CS, Wu JY, Hung YT, Ho MS, et al. (2006) Han Chinese cell and genome bank in Taiwan: purpose, design and ethical considerations. Hum Hered 61: 27-30.
22. Glaab WE, Skopek TR, (1999) A novel assay for allelic discrimination that combines the fluorogenic 5′ nuclease polymerase chain reaction (TaqMan) and mismatch amplification mutation assay. Mutat Res 430: 1-12.
23. Pusch W, Wurmbach JH, Thiele H, Kostrzewa M, (2002) MALDI-TOF mass spectrometry-based SNP genotyping. Pharmacogenomics 3: 537-548.
24. Fujimura T, Yokota M, Kato S, Hirayama H, Tsunekawa A, et al. (1997) Lack of association of angiotensin converting enzyme gene polymorphism or serum enzyme activity with coronary artery disease in Japanese subjects. Am J Hypertens 10: 1384-1390.
25. Laird NM, Horvath S, Xu X, (2000) Implementing a unified approach to family-based tests of association. Genet Epidemiol 19Suppl 1: S36-42.
26. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
27. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, et al. (2002) The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
28. Zeger SL, Liang KY, (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42: 121-130.
29. Corvol P WT, Soubrier F (1995) Peptidyl dipeptidase A: angiotensin I- converting enzyme, in: Barrett, A. J. (Eds.), Methods in Enzymology. London: Academic Press Inc. 283-305 p.
30. Corvol P WT, Soubrier F (1998) Peptidyl-dipeptidase A/angiotensin 1-converting enzyme, in: Barrett AJ, Rawlings ND, Woessner JF (Eds.), in Handbook of Proteolytic Enzymes. San Diego: Academic Press Inc. 1066-1076 p.
31. Liu X, Fernandez M, Wouters MA, Heyberger S, Husain A, (2001) Arg(1098) is critical for the chloride dependence of human angiotensin I-converting enzyme C-domain catalytic activity. J Biol Chem 276: 33518-33525.
32. Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A, (2003) Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol 23: 1269-1275.
33. Niu T, Chen X, Xu X, (2002) Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications. Drugs 62: 977-993.